https://seekingalpha.com/news/3340083-medicare-cover-foundat…
Medicare (CMS) to cover FMI’s tests.
Foundation Medicine (NASDAQ:FMI) announces that the U.S. Centers for Medicare & Medicaid Services (CMS) has OK’d reimbursement for its FoundationOne CDx comprehensive next-generation sequencing (NGS) genomic profiling assay for all solid tumors incorporating a broad range of companion diagnostics, the only test to meet the requirements for coverage.
Rob